Fast Facts
Contact Info and Support
Traffic information
| Category | Metrics | Meaning |
|---|---|---|
| Ratings | Global Rank | - |
| Country Code | - | |
| Country Rank | - | |
| Category Rank | - | |
| Engagement metrics | Visits | 0 |
| Bounce Rate | 0 | |
| Pageviews per Visit | 0 | |
| Avg. Visit Duration | 0 | |
| Estimated monthly visits | July 2025 | 0 |
| August 2025 | 0 | |
| September 2025 | 0 | |
| Traffic sources | Social | - |
| Paid Referrals | - | |
| - | ||
| Referrals | - | |
| Search | - | |
| Direct | - |
About Commercial M Suit
Commercial‑M‑Suit, operated by P24O Ltd., presents itself as regulated by the Malta Financial Services Authority (MFSA) under a Category 3 Investment Services License—License No.: IS/56519—and claims MiFID compliance and provision of negative balance protection, investor compensation up to €20,000 (90% of investment), and segregated client funds. The platform offers trading in more than 70 assets—including forex, futures, indices, metals, energy, and cryptocurrencies—with leverage up to 1:100 for professional traders and uses the MetaTrader 5 (MT5) ECN platform. Notwithstanding these claims, independent verification by financial watchdog sources found no matching records in the MFSA register nor in FCA, CONSOB, BaFin, or AMF registries, indicating the broker is actually unregulated.
There is a direct conflict between the firm’s website assertions of MFSA authorisation and independent registry findings; regulatory registry information takes precedence over self‑claims. Investor protection mechanisms (negative balance protection, compensation scheme) are therefore unverified and cannot be relied upon.
Pros and cons
Pros
- Presents a wide range of asset classes including forex, indices, metals, energy, futures, and cryptocurrencies.
- Offers ECN trading via the popular MT5 platform with leverage up to 1:100 for professional traders (as claimed on site).
Cons
- Self‑declared regulation by MFSA (License No.: IS/56519) is not confirmed in official MFSA records—Commercial‑M‑Suit is unregulated according to independent sources.
- No verifiable investor protection or legal recourse; claims of compensation and fund segregation lack regulatory backing.
- High risk to clients due to absence of any confirmed regulatory oversight.













